Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07130539 · ClinicalTrials.gov registry record · NA

Mediterranean-DASH Intervention for Neurodegenerative Delay and High-Intensity Interval Training in Adults With Hypertension

A NA study of Obesity &Amp; Overweight and Sedentary, sponsored by Texas Woman's University.

Active
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT07130539 is a NA study of Obesity &Amp; Overweight and Sedentary that is active but no longer recruiting, run by Texas Woman's University. The registered enrollment target is 10 participants, below the 104-participant average among 8 other Obesity &Amp; Overweight trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07130539, a NA study of Obesity &Amp; Overweight and Sedentary, is active but no longer recruiting, sponsored by Texas Woman's University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

This pilot study examines whether a 4-week diet and exercise intervention can improve blood pressure, heart health, and sleep in physically inactive individuals with high blood pressure and overweight or obesity.

Interventions

  • OTHER MIND HIIT

Study Locations (1)

Texas

  • Texas Woman's University Houston Center - Houston

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2025-03-11
Est. Completion 2025-12-25
Phase NA

Sponsor

Texas Woman's University

51 total trials

What the Registry Record Tells You About NCT07130539

The ClinicalTrials.gov registry entry for NCT07130539 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 104-participant average among 8 other Obesity &Amp; Overweight trials with a reported enrollment target (90% lower). The listed sponsor is Texas Woman's University, which has 51 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Obesity &Amp; Overweight appearing as the primary indexed condition, and to 1 intervention - of which MIND HIIT is the first listed.

NCT07130539 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT07130539 about?

NCT07130539 is a clinical study titled "Mediterranean-DASH Intervention for Neurodegenerative Delay and High-Intensity Interval Training in Adults With Hypertension". This pilot study examines whether a 4-week diet and exercise intervention can improve blood pressure, heart health, and sleep in physically inactive individuals with high blood pressure and overweight or obesity.

What is the current status of trial NCT07130539?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-03-11. Estimated completion is 2025-12-25.

What conditions does trial NCT07130539 study?

This clinical trial studies the following conditions: Obesity &Amp; Overweight, Sedentary, Hypertension (HTN).

What interventions are being tested in trial NCT07130539?

The interventions under investigation include: MIND HIIT (OTHER).

Who is sponsoring clinical trial NCT07130539?

This trial is sponsored by Texas Woman's University, which has 51 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07130539 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity &Amp; Overweight

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.